journal article·2024-03Open access

Hydrogel Crosslinked with Nanoparticles for Prevention of Surgical Hemorrhage and Recurrence of Hepatocellular Carcinoma

Jia‐Qi Zhu, Han Wu, Xu Li, Min‐Yu Li, Zhen‐Li Li, Xin‐Fei Xu, Li‐Hui Gu, Dong‐Xu Yin, Feng Shen, Dong‐Sheng Huang, Tian Yang

Advanced Science· Volume 11· Issue 9

Abstract

Abstract Hepatocellular carcinoma (HCC) is acknowledged as an immunosuppressive neoplasm, whereby the inactive microenvironment facilitates immune tolerance and evasion of HCC. Post‐surgical resected liver cancer exhibits a proclivity for relapse, rendering prevention of recurrence challenging as it may transpire at any point subsequent to surgery. Among the various anti‐recurrence interventions, the primary clinical approach involving the administration of regimens atezolizumab and bevacizumab (A+T) is deemed the most efficacious in reversing the tumor microenvironment, albeit still lacking in complete satisfaction. Therefore, the objective is to utilize a recently developed block copolymer as a protective carrier for two specific monoclonal antibody drugs. Subsequently, a modified hemostatic hydrogel will be synthesized for application during hepatic surgery. The immunotherapy impact of this approach is significantly prolonged and intensified due to the combined hemostasis properties and controlled release of the constituents within the synthesized nanocomposite hydrogel. Furthermore, these nanocomposite hydrogels exhibit remarkable efficacy in preventing postoperative wound bleeding and substantially enhancing the safety of liver cancer resection. This research on the anti‐recurrence hydrogel system presents a novel therapeutic approach for addressing local recurrence of liver cancer, potentially offering a substantial contribution to the field of surgical treatment for liver cancer in the future.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Nanoplatforms for cancer theranostics · Immune cells in cancer

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Hepatobiliary Surgery Eastern Hepatobiliary Surgery Hospital Second Military Medical University (Naval Medical University) Shanghai 200438 China

College of Biotechnology and Bioengineering Zhejiang University of Technology Hangzhou Zhejiang 310014 China

Department of Colorectal Surgery The First Affiliated Hospital of Naval Medical University Shanghai 200433 China

Department of Special Care Unit The First Affiliated Hospital of Naval Medical University Shanghai 200433 China

School of Clinical Medicine Hangzhou Medical College Hangzhou Zhejiang 310014 China

The Key Laboratory of Tumor Molecular Diagnosis and Individualized Medicine of Zhejiang Province Zhejiang Provincial People's Hospital (People's Hospital of Hangzhou Medical College) Hangzhou Zhejiang 310014 China

Funding

National Natural Science Foundation of China · National Outstanding Youth Science Fund Project of National Natural Science Foundation of China

References (37)

Show source-provided references
1. 10.1016/j.jhep.2021.11.01810.1016/j.jhep.2021.11.018 ↗
2. 10.1001/jamaoncol.2018.270610.1001/jamaoncol.2018.2706 ↗
3. 10.1016/j.jhep.2020.03.00510.1016/j.jhep.2020.03.005 ↗
4. 10.1002/adfm.20200471310.1002/adfm.202004713 ↗
5. 10.1038/nri348810.1038/nri3488 ↗
6. 10.1038/s41573-018-0006-z10.1038/s41573-018-0006-z ↗
7. 10.1002/adma.20210111010.1002/adma.202101110 ↗
8. 10.1038/s41565-020-00822-y10.1038/s41565-020-00822-y ↗
9. 10.1038/s41577-019-0269-610.1038/s41577-019-0269-6 ↗
10. 10.1016/j.jhep.2021.07.00410.1016/j.jhep.2021.07.004 ↗
11. 10.1136/gutjnl-2020-32170210.1136/gutjnl-2020-321702 ↗
12. 10.1002/advs.20230051710.1002/advs.202300517 ↗
13. 10.1002/advs.20230063710.1002/advs.202300637 ↗
14. 10.1038/s41565-020-00843-710.1038/s41565-020-00843-7 ↗
15. 10.1038/s41591-022-01868-210.1038/s41591-022-01868-2 ↗
16. 10.1021/acs.accounts.9b0011410.1021/acs.accounts.9b00114 ↗
17. 10.1038/nmat449710.1038/nmat4497 ↗
18. 10.1126/sciadv.170018410.1126/sciadv.1700184 ↗
19. Roshanbinfar K. · Adv. Mater. · 2018 · 28
20. 10.1039/C9TB02523E10.1039/C9TB02523E ↗
21. 10.1016/j.cej.2020.12532010.1016/j.cej.2020.125320 ↗
22. Yang J. W. · Adv. Mater. · 2020 · 30
23. 10.1002/adma.20200162810.1002/adma.202001628 ↗
24. 10.1038/s41565-018-0319-410.1038/s41565-018-0319-4 ↗
25. 10.1039/c2cs15327k10.1039/c2cs15327k ↗
26. 10.1039/C7CS00460E10.1039/C7CS00460E ↗
27. 10.1039/C5SM00820D10.1039/C5SM00820D ↗
28. 10.1016/j.addr.2009.04.01610.1016/j.addr.2009.04.016 ↗
29. 10.1039/C6CS00013D10.1039/C6CS00013D ↗
30. 10.1002/adhm.20180002010.1002/adhm.201800020 ↗
31. 10.1021/ja406406h10.1021/ja406406h ↗
32. 10.1021/nn500498t10.1021/nn500498t ↗
33. 10.1021/mp500162w10.1021/mp500162w ↗
34. 10.1021/mz300568b10.1021/mz300568b ↗
35. 10.1016/j.biomaterials.2014.04.03410.1016/j.biomaterials.2014.04.034 ↗
36. 10.1021/jacs.7b1277610.1021/jacs.7b12776 ↗
37. 10.1021/acs.chemrev.0c0117710.1021/acs.chemrev.0c01177 ↗